Osteoporosis
Osteoporosis
01/18/2019
An advisory panel to the FDA has recommended the approval of a new treatment option for use in postmenopausal women with osteoporosis and high fracture risk.
01/18/2019
Osteoporosis
Osteoporosis
01/18/2019
An advisory panel to the FDA has recommended the approval of a new treatment option for use in postmenopausal women with osteoporosis and high fracture risk.
01/18/2019
Seizure
Seizure
01/11/2019
The medication is to be used as an adjunctive therapy in adult and pediatric patients with complex partial seizures.
01/11/2019
Seizure
Seizure
01/11/2019
The medication is to be used as an adjunctive therapy in adult and pediatric patients with complex partial seizures.
01/11/2019
Seizure
Seizure
01/11/2019
The medication is to be used as an adjunctive therapy in adult and pediatric patients with complex partial seizures.
01/11/2019
FDA
FDA
12/27/2018
The US Food and Drug Administration has granted approval to a new vaccine for young children that protects against 6 diseases.
12/27/2018
FDA
FDA
12/27/2018
The US Food and Drug Administration has granted approval to a new vaccine for young children that protects against 6 diseases.
12/27/2018
FDA
FDA
12/27/2018
The US Food and Drug Administration has granted approval to a new vaccine for young children that protects against 6 diseases.
12/27/2018
FDA
FDA
12/20/2018
The FDA has approved a selective serotonin-4 (5-HT4) receptor agonist to treat adults with chronic idiopathic constipation, a condition that affects 14% of the adult population.
12/20/2018
Multiple Sclerosis
Multiple Sclerosis
11/26/2018
The FDA has released a warning about the potential for an increase in disability in patients with multiple sclerosis who stop taking this immunosuppressant.
11/26/2018